John Huang

Title: Innovations in Intraocular Drug Delivery by John Huang

Introduction

John Huang is an accomplished inventor based in Hamden, CT (US). He has made significant contributions to the field of ophthalmology through his innovative patent focused on drug delivery systems. His work aims to improve the management of eye diseases and disorders, particularly those related to intraocular pressure.

Latest Patents

John Huang holds a patent for "Sustained intraocular delivery of drugs from biodegradable polymeric microparticles." This invention describes biodegradable polymeric microparticle compositions that contain one or more active agents useful for treating or preventing diseases of the eye. A preferred embodiment of this invention includes microparticle compositions that manage elevated intraocular pressure (IOP) using relatively hydrophilic, carboxylated polymeric materials such as PLGA. The invention utilizes drugs like timolol maleate, which is water-soluble, to enhance drug loading. The design incorporates higher molecular weight polymers and a specific ratio of lactic acid (LA) to glycolic acid (GA) to ensure prolonged drug release over one to two years.

Career Highlights

Throughout his career, John Huang has worked with prestigious institutions such as Yale University and the University of Iowa Research Foundation. His experience in these research environments has allowed him to develop and refine his innovative approaches to drug delivery.

Collaborations

John Huang has collaborated with notable professionals in his field, including Erin Lavik and Young H Kwon. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

John Huang's contributions to intraocular drug delivery represent a significant advancement in ophthalmic treatments. His innovative approach to using biodegradable polymeric microparticles has the potential to improve patient outcomes in managing eye diseases.